日本語View as Markdown

Role of molecular hydrogen in obesity treatment: modulation of GLP-1, irisin, and PGC-1α for improved metabolism.

肥満における分子状水素の役割:GLP-1・イリシン・PGC-1αを介した代謝改善の可能性

review not specified not assessed

Abstract

This article examines the potential role of molecular hydrogen (H2) in addressing obesity-related metabolic disturbances. The discussion centers on three key metabolic regulators: glucagon-like peptide-1 (GLP-1), irisin, and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α). These factors are involved in energy homeostasis, lipid metabolism, and mitochondrial biogenesis. The paper proposes that H2 may exert beneficial metabolic effects in obesity by modulating these pathways, though the precise mechanisms and clinical evidence require further investigation.

Mechanism

H2 is proposed to improve energy metabolism and mitochondrial function in obesity by upregulating GLP-1 secretion, increasing irisin expression, and activating PGC-1α, collectively modulating lipid and glucose homeostasis.

Bibliographic

Authors
Todorović N, Kuzmanovic J, Javorac D, Ostojic SM
Journal
Med Gas Res
Year
2025 (2025-09-01)
PMID
40251025
DOI
10.4103/mgr.MEDGASRES-D-24-00146
PMC
PMC12054667

Tags

Mechanism:抗酸化酵素 炎症抑制 脂質過酸化 ミトコンドリア 酸化ストレス

Delivery context

The delivery route is not clearly identifiable from this paper. For hydrogen intake, inhalation is the most efficient route; inhalation, however, carries explosion risk (empirical LFL of 10%; high-concentration devices are not recommended).

Safety notes

The delivery route is not clearly identifiable from this paper. For hydrogen intake, inhalation is the most efficient route; inhalation, however, carries explosion risk (empirical LFL of 10%; high-concentration devices are not recommended).

See also:

Cite as: H2 Papers — PMID 40251025. https://h2-papers.org/en/papers/40251025
Source: PubMed PMID 40251025